Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib in Subjects With Actinic Keratoses
NCT00027976Phase 3Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Dec 2001
- Primary completion
- Dec 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of celecoxib in actinic keratosis (AK), sponsored by University of Alabama at Birmingham. Planned start Dec 2001; status: withdrawn.
02
Drugs
celecoxib
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT00027976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00027976.